Impact Biomedical IBO
NYSE IBO
$5.46 -0.14 (-2.50%)
As of: Oct 1, 2026 · 3:57 PM EDT

Impact Biomedical (IBO) EBIT (2022 - 2026)

Updated

Impact Biomedical (IBO) reported EBIT of -$702,000 for Q2 2026, compared with -$1.15 million a year earlier.

Analysis

Impact Biomedical (IBO) EBIT (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Impact Biomedical's EBIT came in at -$5.09 million; for FY2024, it was -$28.75 million.

  • By year, EBIT came in at -$4.03 million in FY2023 and -$3.4 million in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly EBIT since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.14 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.43 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.16 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.39 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Impact Biomedical 598.41 Mn 601.61 Mn 2,000.00 -702,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -702,000.00
Mar 31, 2026 -2.29 Mn
Sep 30, 2025 -948,000.00
Jun 30, 2025 -1.15 Mn
Mar 31, 2025 -1.01 Mn
Dec 31, 2024 -26.23 Mn
Sep 30, 2024 -1.13 Mn
Jun 30, 2024 -626,000.00
Mar 31, 2024 -771,000.00
Dec 31, 2023 -1.14 Mn
Sep 30, 2023 -1.08 Mn
Jun 30, 2023 -1.01 Mn
Mar 31, 2023 -803,000.00
Dec 31, 2022 -1.03 Mn
Sep 30, 2022 -889,000.00
Jun 30, 2022 -750,000.00
API Access

Impact Biomedical EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=IBO&period=max&api_key=YOUR_API_KEY